Table 4 All assessments scores overtime and between-group differences at 6-month follow-up

SF-12 PCS

40.216±0.935

41.442±1.217

42.113±0.875

42.969±1.189

44.212±0.816

47.489±0.960

-3.277 (-6.974, 0.42)

0.139

SF-12 MCS

37.317±1.054

34.268±1.058

48.579±0.763

40.036±0.894

50.261±0.758

45.208±0.887

5.053 (1.628, 8.478)

<0.001

GAD

7.311±0.570

8.911±0.616

4.614±0.428

8.636±0.535

4.150±0.347

8.022±0.423

-3.872 (-5.476, -2.270)

<0.001

PHQ

11.111±0.916

11.889±0.885

9.568±0.822

11.004±0.697

8.419±0.713

10.409±0.741

-1.990 (-5.010,1.027)

0.794

BIPQ

45.133±0.941

49.40±1.196

38.679±0.603

46.532 ± 0.754

34.700±0.432

38.026±0.318

-3.356

(-4.931, -1.781)

<0.001

AFSS symptoms scale

11.222±0.370

10.890±0.321

10.525±0.228

11.280±0.217

9.890±0.217

10.928±0.218

-1.040 (-1.944, -0.137)

0.011